The Origin of Allosteric Functional Modulation: Multiple Pre-existing Pathways

Structure

Volumn 17, Issue 8, 2009, Pages 1042-1050

  del Sol, Antonio ^a   Tsai, Chung Jung ^b   Ma, Buyong ^b   Nussinov, Ruth ^b,c  

^a FUJIREBIO INC   (Japan)

^b SAIC FREDERICK INC   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

PROTEINS

Indexed keywords

PROTEIN;

ALLOSTERISM; BINDING AFFINITY; COVALENT BOND; DRUG BINDING; MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION;

ALLOSTERIC REGULATION; BINDING SITES; DRUG DESIGN; MODELS, MOLECULAR; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SIGNAL TRANSDUCTION;

EID: 68149157248     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2009.06.008     Document Type: Review

References (79)

1. Ansari A., Berendzen J., Bowne S.F., Frauenfelder H., Iben I.E.T., Sauke T.B., Shyamsunder E., and Young R.D. Protein states and protein quakes. Proc. Natl. Acad. Sci. USA 82 (1985) 5000-5004
2. Berman H.M., Battistuz T., Bhat T.N., Bluhm W.F., Bourne P.E., Burkhardt K., Feng Z., Gilliland G.L., Iype L., Jain S., et al. The Protein Data Bank. Acta Crystallogr. D Biol. Crystallogr. 58 (2002) 899-907
3. Boehr D.D., McElheny D., Dyson H.J., and Wright P.E. The dynamic energy landscape of dihydrofolate reductase catalysis. Science 313 (2006) 1638-1642
4. Bogoyevitch M.A., and Fairlie D.P. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding. Drug Discov. Today 12 (2007) 622-633
5. Bruschweiler S., Schanda P., Kloiber K., Brutscher B., Kontaxis G., Konrat R., and Tollinger M. Direct observation of the dynamic process underlying allosteric signal transmission. J. Am. Chem. Soc. 131 (2009) 3063-3068
6. Bullock A.N., Rodriguez M.C., Debreczeni J.E., Songyang Z., and Knapp S. Structure of the SOCS4-ElonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation. Structure 15 (2007) 1493-1504
7. Burack W.R., and Shaw A.S. Signal transduction: hanging on a scaffold. Curr. Opin. Cell Biol. 12 (2000) 211-216
8. Changeux J.P., and Edelstein S.J. Allosteric mechanisms of signal transduction. Science 308 (2005) 1424-1428
9. Chennubhotla C., and Bahar I. Markov propagation of allosteric effects in biomolecular systems: application to GroEL-GroES. Mol. Syst. Biol. 2 (2006) 36
10. Conn P.J., Jones C.K., and Lindsley C.W. Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol. Sci. 30 (2009) 148-155
11. Cooper A., and Dryden D.T.F. Allostery without conformational change: a plausible model. Eur. Biophys. J. 11 (1984) 103-109
12. Cui Q., and Karplus M. Allostery and cooperativity revisited. Protein Sci. 17 (2008) 1295-1307
13. Daily M.D., and Gray J.J. Local motions in a benchmark of allosteric proteins. Proteins 67 (2007) 385-399
14. Daily M.D., and Gray J.J. Allosteric communication occurs via networks of tertiary and quaternary motions in proteins. PLoS Comput. Biol. 5 (2009) e1000293
15. Datta D., Scheer J.M., Romanowski M.J., and Wells J.A. An allosteric circuit in caspase-1. J. Mol. Biol. 381 (2008) 1157-1167
16. del Sol A., Fujihashi H., Amoros D., and Nussinov R. Residues crucial for maintaining short paths in network communication mediate signaling in proteins. Mol. Syst. Biol. 2 (2006) 2006.0019
17. del Sol A., Arauzo-Bravo M.J., Amoros D., and Nussinov R. Modular architecture of protein structures and allosteric communications: potential implications for signaling proteins and regulatory linkages. Genome Biol. 8 (2007) R92
18. Demarest S.J., Martinez-Yamout M., Chung J., Chen H., Xu W., Dyson H.J., Evans R.M., and Wright P.E. Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature 415 (2002) 549-553
19. Formaneck M.S., Ma L., and Cui Q. Reconciling the "old" and "new" views of protein allostery: A molecular simulation study of chemotaxis Y protein (CheY). Proteins 63 (2006) 846-867
20. Fuentes E.J., Der C.J., and Lee A.L. Ligand-dependent dynamics and intramolecular signaling in a PDZ domain. J. Mol. Biol. 335 (2004) 1105-1115
21. Good M., Tang G., Singleton J., Reményi A., and Lim W.A. The Ste5 scaffold directs mating signaling by catalytically unlocking the Fus3 MAP kinase for activation. Cell 136 (2009) 1085-1097
22. Goodey N.M., and Benkovic S.J. Allosteric regulation and catalysis emerge via a common route. Nat. Chem. Biol. 4 (2008) 474-482
23. Goto N.K., Zor T., Martinez-Yamout M., Dyson H.J., and Wright P.E. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain. J. Biol. Chem. 277 (2002) 43168-43174
24. Gunasekaran K., Ma B., and Nussinov R. Is allostery an intrinsic property of all dynamic proteins?. Proteins 57 (2004) 433-443
25. Hao B., Oehlmann S., Sowa M.E., Harper J.W., and Pavletich N.P. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol. Cell 26 (2007) 131-143
26. Hardy J.A., Lam J., Nguyen J.T., O'Brien T., and Wells J.A. Discovery of an allosteric site in the caspases. Proc. Natl. Acad. Sci. USA 101 (2004) 12461-12466
27. Horovitz A., and Fersht A.R. Strategy for analyzing the cooperativity of intramolecular interactions in peptides and proteins. J. Mol. Biol. 214 (1990) 613-617
28. Horovitz A., and Fersht A.R. Cooperative interactions during protein folding. J. Mol. Biol. 224 (1992) 733-740
29. Hu Z., Bowen D., Southerland W.M., del Sol A., Pan Y., Nussinov R., and Ma B. Ligand binding and circular permutation modify residue interaction network in DHFR. PLoS Comput. Biol. 3 (2007) e117
30. Jin Y., Zeng S.X., Dai M.S., Yang X.J., and Lu H. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J. Biol. Chem. 277 (2002) 30838-30843
31. Kalatskaya I., Berchiche Y.A., Gravel S., Limberg B.J., Rosenbaum J.S., and Heveker N. AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol. Pharmacol. 75 (2009) 1240-1247
32. Kenakin T. Allosteric agonist modulators. J. Recept. Signal Transduct. Res. 27 (2007) 247-259
33. Kern D., and Zuiderweg E.R. The role of dynamics in allosteric regulation. Curr. Opin. Struct. Biol. 13 (2003) 748-757
34. Keskin O., and Nussinov R. Similar binding sites and different partners: Implications to shared proteins in cellular pathways. Structure 15 (2007) 341-354
35. Kjarland E., Keen T.J., and Kleppe R. Does isoform diversity explain functional differences in the 14-3-3 protein family?. Curr. Pharm. Biotechnol. 7 (2006) 217-223
36. Knauth K., Bex C., Jemth P., and Buchberger A. Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions. Oncogene 25 (2006) 370-377
37. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6 (2005) 827-837
38. Komurov K., and White M. Revealing static and dynamic modular architecture of the eukaryotic protein interaction network. Mol. Syst. Biol. 3 (2007) 110
39. Koshland D.E., Nemethy G., and Filmer D. Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry 5 (1966) 365-385
40. Kozlov G., Banville D., Gehring K., and Ekiel I. Solution structure of the PDZ2 domain from cytosolic human phosphatase hPTP1E complexed with a peptide reveals contribution of the beta2-beta3 loop to PDZ domain-ligand interactions. J. Mol. Biol. 320 (2002) 813-820
41. Kruse J.P., and Gu W. Modes of p53 regulation. Cell 137 (2009) 609-622
42. Kumar S., Ma B., Tsai C.J., Sinha N., and Nussinov R. Folding and binding cascades: dynamic landscapes and population shifts. Protein Sci. 9 (2000) 10-19
43. Langmead C.J., and Christopoulos A. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox. Trends Pharmacol. Sci. 27 (2006) 475-481
44. Linares L.K., Kiernan R., Triboulet R., Chable-Bessia C., Latreille D., Cuvier O., Lacroix M., Le Cam L., Coux O., and Benkirane M. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat. Cell Biol. 9 (2007) 331-338
45. Liu J., and Nussinov R. Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design. Proc. Natl. Acad. Sci. USA 105 (2008) 901-906
46. Lockless S.W., and Ranganathan R. Evolutionarily conserved pathways of energetic connectivity in protein families. Science 286 (1999) 295-299
47. Luo J., Li M., Tang Y., Laszkowska M., Roeder R.G., and Gu W. Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc. Natl. Acad. Sci. USA 101 (2004) 2259-2264
48. Lupardus P.J., Shen A., Bogyo M., and Garcia K.C. Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain. Science 322 (2008) 265-268
49. Ma B., Kumar S., Tsai C.J., and Nussinov R. Folding funnels and binding mechanisms. Protein Eng. 12 (1999) 713-720
50. Ma B., and Nussinov R. Amplification of signaling via cellular allosteric relay and protein disorder. Proc. Natl. Acad. Sci. USA 106 (2009) 6887-6888
51. Ma B., Shatsky M., Wolfson H.J., and Nussinov R. Multiple diverse ligands binding at a single protein site: A matter of pre-existing populations. Protein Sci. 11 (2002) 184-197
52. Mahanty S.K., Wang Y.M., Farley F.W., and Elion E.A. Nuclear shuttling of yeast scaffold Ste5 is required for its recruitment to the plasma membrane and activation of the mating MAPK cascade. Cell 98 (1999) 501-512
53. Maillet E.L., Pellegrini N., Valant C., Bucher B., Hibert M., Bourguignon J.J., and Galzi J.L. A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties. FASEB J. 21 (2007) 2124-2134
54. Martin K., Trouche D., Hagemeier C., Sorensen T.S., La Thangue N.B., and Kouzarides T. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375 (1995) 691-694
55. Monod J., Wyman J., and Changeux J.P. On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 12 (1965) 88-118
56. Morimoto R.I. Dynamic remodeling of transcription complexes by molecular chaperones. Cell 110 (2002) 281-284
57. Ohh M., Park C.W., Ivan M., Hoffman M.A., Kim T.Y., Huang L.E., Pavletich N., Chau V., and Kaelin W.G. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2 (2000) 423-427
58. Pelkey K.A., Yuan X., Lavezzari G., Roche K.W., and McBain C.J. mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082. Neuropharmacology 52 (2007) 108-117
59. Popovych N., Sun S., Ebright R.H., and Kalodimos C.G. Dynamically driven protein allostery. Nat. Struct. Mol. Biol. 13 (2006) 831-838
60. Quiniou C., Sapieha P., Lahaie I., Hou X., Brault S., Beauchamp M., Leduc M., Rihakova L., Joyal J.S., Nadeau S., et al. Development of a novel noncompetitive antagonist of IL-1 receptor. J. Immunol. 180 (2008) 6977-6987
61. Redka D.S., Pisterzi L.F., and Wells J.W. Binding of orthosteric ligands to the allosteric site of the M-2 muscarinic cholinergic receptor. Mol. Pharmacol. 74 (2008) 834-843
62. Riley T., Sontag E., Chen P., and Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 9 (2008) 402-412
63. Sadovsky E., and Yifrach O. Principles underlying energetic coupling along an allosteric communication trajectory of a voltage-activated K+ channel. Proc. Natl. Acad. Sci. USA 104 (2007) 19813-19818
64. Seeliger M.A., and Kuriyan J. A MAPK scaffold lends a helping hand. Cell 136 (2009) 994-996
65. Sethi A., Eargle J., Black A.A., and Luthey-Schulten Z. Dynamical networks in tRNA:protein complexes. Proc. Natl. Acad. Sci. USA 106 (2009) 6620-6625
66. Smock R.G., and Gierasch L.M. Sending signals dynamically. Science 324 (2009) 198-203
67. Sombroek D., and Hofmann T.G. How cells switch HIPK2 on and off. Cell Death Differ. 16 (2009) 187-194
68. Suel G.M., Lockless S.W., Wall M.A., and Ranganathan R. Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nat. Struct. Biol. 10 (2003) 59-69
69. Swain J.F., and Gierasch L.M. The changing landscape of protein allostery. Curr. Opin. Struct. Biol. 16 (2006) 102-108
70. Trible R.P., Emert-Sedlak L., Wales T.E., Ayyavoo V., Engen J.R., and Smithgall T.E. Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor. J. Mol. Biol. 374 (2007) 121-129
71. Tsai C.J., Del Sol A., and Nussinov R. Allostery: absence of a change in shape does not imply that allostery is not at play. J. Mol. Biol. 378 (2008) 1-11
72. Tsai C.J., Del Sol A., and Nussinov R. Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms. Mol. Biosyst. 5 (2009) 207-216
73. Tsai C.J., Ma B., and Nussinov R. Folding and binding cascades: shifts in energy landscapes. Proc. Natl. Acad. Sci. USA 96 (1999) 9970-9972
74. Tuncbag N.K.G., Gursoy A., Keskin O., and Nussinov R. Inferring time dimensionality in the protein-protein interaction networks by integrating structures: the p53 example. Mol. Biosyst. (2009) 10.1039/B905661K in press. Published online June 30, 2009
75. Ubersax J.A., and Ferrell J.E. Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 8 (2007) 530-541
76. Volkman B.F., Lipson D., Wemmer D.E., and Kern D. Two-state allosteric behavior in a single-domain signaling protein. Science 291 (2001) 2429-2433
77. Yao X., Rosen M.K., and Gardner K.H. Estimation of the available free energy in a LOV2-J alpha photoswitch. Nat. Chem. Biol. 4 (2008) 491-497
78. Yoshimura A., Naka T., and Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7 (2007) 454-465
79. Zhang Z., Wang H., Li M., Rayburn E.R., Agrawal S., and Zhang R. Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway. Oncogene 24 (2005) 7238-7247